Magnus Andreas Hvistendahl
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Magnus Andreas Hvistendahl has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Mats Bue
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
7 shared publications - Maiken Stilling
Aarhus University Hospital
6 shared publications - Pelle Hanberg
Department of Otorhinolaryngology, Head and Neck Surgery, Aarhus University Hospital, Aarhus, Denmark
5 shared publications Kristian Høy
Department of Clinical Medicine Aarhus University Aarhus N Denmark
4 shared publications- Alexander Emil Kaspersen
Department of Cardiothoracic & Vascular Surgery, Aarhus University Hospital, Palle Juul-Jensens, Aarhus N, Denmark
3 shared publications - Anne Vibeke Schmedes
Department of Biochemistry and Immunology, Lillebaelt Hospital, University Hospital of Southern, Vejle, Denmark
2 shared publications
Latest Publications
- Open Access
- 24 September 2026
- Published by Elsevier in Journal of Orthopaedic Translation
Large animal models of traumatic long-bone fractures and fracture-related infection: A scoping review
- 24 September 2026
- Published by Elsevier in Journal of Orthopaedic Translation
Open AccessLarge animal models of traumatic long-bone fractures and fracture-related infection: A scoping review
- Open Access
- 1 October 2025
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 69 (10) , e0079225
Piperacillin reaches high concentrations in bile and target tissues of the biliary system: an experimental study in pigs
The antibiotic combination of piperacillin/tazobactam (TZP) is commonly utilized for preventing and treating infections in the biliary system, with piperacillin being the primary agent. Its effectiveness is closely related to the time with concentrations above the minimal inhibitory concentration ( T > MIC) of the bacteria involved. The most frequently encountered bacteria associated with biliary system infections present with clinical breakpoint MIC values of 8 and 16 µg/mL. This porcine study aimed to apply microdialysis to assess target site piperacillin T > MIC 8, 16, and 32 (4× MIC 8) µg/mL in the biliary system. In eight healthy pigs (Danish Landrace breed, weight 78–82 kg), five microdialysis catheters were placed for sampling of piperacillin concentrations in the liver, the wall of the gallbladder, the bile in the gallbladder, the wall of the common bile duct (CBD), and the bile in the CBD. A bolus of TZP 4/0.5 g was administered intravenously, and microdialysates and blood samples were collected during an 8 h period. Ultrahigh performance liquid chromatography (UHPLC) was used to quantify the piperacillin concentrations. The mean T > MIC (%T > MIC) varied from 345 to 446 min (77%–99%), 261–446 min (58%–99%), and 200–444 min (42%–99%) for the MIC targets of 8, 16, and 32 µg/mL, respectively. The pharmacokinetic parameters in the bile were found to be different compared to the remaining compartments with higher AUC 0–8h and C max values and longer T 1/2 . Piperacillin displayed prolonged T > MIC in bile compared to plasma and the target tissues of the biliary system, approaching 100% T > MIC for the MIC targets of 8, 16, and 32 µg/mL.
- 1 October 2025
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 69 (10) , e0079225
Open AccessPiperacillin reaches high concentrations in bile and target tissues of the biliary system: an experimental study in pigs
The antibiotic combination of piperacillin/tazobactam (TZP) is commonly utilized for preventing and treating infections in the biliary system, with piperacillin being the primary agent. Its effectiveness is closely related to the time with concentrations above the minimal inhibitory concentration ( T > MIC) of the bacteria involved. The most frequently encountered bacteria associated with biliary system infections present with clinical breakpoint MIC values of 8 and 16 µg/mL. This porcine study aimed to apply microdialysis to assess target site piperacillin T > MIC 8, 16, and 32 (4× MIC 8) µg/mL in the biliary system. In eight healthy pigs (Danish Landrace breed, weight 78–82 kg), five microdialysis catheters were placed for sampling of piperacillin concentrations in the liver, the wall of the gallbladder, the bile in the gallbladder, the wall of the common bile duct (CBD), and the bile in the CBD. A bolus of TZP 4/0.5 g was administered intravenously, and microdialysates and blood samples were collected during an 8 h period. Ultrahigh performance liquid chromatography (UHPLC) was used to quantify the piperacillin concentrations. The mean T > MIC (%T > MIC) varied from 345 to 446 min (77%–99%), 261–446 min (58%–99%), and 200–444 min (42%–99%) for the MIC targets of 8, 16, and 32 µg/mL, respectively. The pharmacokinetic parameters in the bile were found to be different compared to the remaining compartments with higher AUC 0–8h and C max values and longer T 1/2 . Piperacillin displayed prolonged T > MIC in bile compared to plasma and the target tissues of the biliary system, approaching 100% T > MIC for the MIC targets of 8, 16, and 32 µg/mL.
- Open Access
- 1 April 2025
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 91 (8) , 2378-2389
First‐time cefuroxime target tissue concentrations in long‐lasting spine surgery: Continuous evaluation after repeated weight‐dosed administrations
Aims: Antimicrobial prophylaxis is central in preventing postoperative spine infections, yet knowledge on clinical target spine tissue concentrations remain limited. Current dosing regimens often involve fixed doses based on empirical knowledge, surrogate measures, non‐clinical evidence and methodology of variying quality. The objective was to continuously evaluate peri‐ and postoperative cefuroxime target tissue concentrations in long‐lasting spine surgery.Methods: Twenty patients scheduled for spine deformity surgery with hypotensive anaesthesia completed the study. Weight‐dosed cefuroxime was administered intravenously (20 mg/kg) to all patients preoperativey and after 4 h. Microdialysis probes were placed in vertebral bone (intraoperative sampling), paravertebral muscle, subcutaneous tissue and profoundly/superficially in the wound. Microdialysates and plasma samples were obtained for up to 12 h. The primary endpoint was the time with cefuroxime concentrations above the minimal inhibitory concentration for Staphylococcus aureus of 4 μg/mL as a percentage (%fT>MIC4).Results: The median cefuroxime %fT>MIC4 (range) of patients' individual surgery time was 100% (100‐100) in all investigated tissues and plasma. Median cefuroxime %fT>MIC4 (range) in the first dosing interval was 93% (93‐93) in vertebral bone, paravertebral muscle and subcutaneous tissue, and 100% (99‐100) in plasma. Median cefuroxime %fT>MIC4 (range) in the second dosing interval was 85% (52‐100) in paravertebral muscle, 94% (52‐100) in subcutaneous tissue, 99% (71‐100) in the profound wound, 100% (72‐100) in the superficial wound, and 70% (42‐100) in plasma.Conclusions: Repeated weight‐dosed intravenous cefuroxime administrations (20 mg/kg) provided homogenous and sufficient intraoperative target tissue exposure of cefuroxime (100% fT>MIC4) in long‐lasting spine surgery with hypotensive anaesthesia and postoperative exposure (>4 μg/mL) for 5.5‐7.5 h.
- 1 April 2025
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 91 (8) , 2378-2389
Open AccessFirst‐time cefuroxime target tissue concentrations in long‐lasting spine surgery: Continuous evaluation after repeated weight‐dosed administrations
Aims: Antimicrobial prophylaxis is central in preventing postoperative spine infections, yet knowledge on clinical target spine tissue concentrations remain limited. Current dosing regimens often involve fixed doses based on empirical knowledge, surrogate measures, non‐clinical evidence and methodology of variying quality. The objective was to continuously evaluate peri‐ and postoperative cefuroxime target tissue concentrations in long‐lasting spine surgery.Methods: Twenty patients scheduled for spine deformity surgery with hypotensive anaesthesia completed the study. Weight‐dosed cefuroxime was administered intravenously (20 mg/kg) to all patients preoperativey and after 4 h. Microdialysis probes were placed in vertebral bone (intraoperative sampling), paravertebral muscle, subcutaneous tissue and profoundly/superficially in the wound. Microdialysates and plasma samples were obtained for up to 12 h. The primary endpoint was the time with cefuroxime concentrations above the minimal inhibitory concentration for Staphylococcus aureus of 4 μg/mL as a percentage (%fT>MIC4).Results: The median cefuroxime %fT>MIC4 (range) of patients' individual surgery time was 100% (100‐100) in all investigated tissues and plasma. Median cefuroxime %fT>MIC4 (range) in the first dosing interval was 93% (93‐93) in vertebral bone, paravertebral muscle and subcutaneous tissue, and 100% (99‐100) in plasma. Median cefuroxime %fT>MIC4 (range) in the second dosing interval was 85% (52‐100) in paravertebral muscle, 94% (52‐100) in subcutaneous tissue, 99% (71‐100) in the profound wound, 100% (72‐100) in the superficial wound, and 70% (42‐100) in plasma.Conclusions: Repeated weight‐dosed intravenous cefuroxime administrations (20 mg/kg) provided homogenous and sufficient intraoperative target tissue exposure of cefuroxime (100% fT>MIC4) in long‐lasting spine surgery with hypotensive anaesthesia and postoperative exposure (>4 μg/mL) for 5.5‐7.5 h.
- 22 November 2024
- Published by British Editorial Society of Bone & Joint Surgery in Orthopaedic Proceedings
- Vol. 106-B (SUPP_19) , 50
FIRST-TIME EVALUATION OF INTRA- AND POSTOPERATIVE CEFUROXIME TARGET SPINE TISSUE CONCENTRATIONS IN LONG-LASTING SPINE SURGERY FOLLOWING REPEATED WEIGHT-DOSED INTRAVENOUS ADMINISTRATIONS
Aim: Antibiotic prophylaxis is central in preventing postoperative spine infections, yet knowledge of clinical spine tissue antibiotic concentrations remains limited. Pooled postoperative spine infection rates are constant (approximately 3%), resulting in severe patient morbidity, mortality, and prolonged hospitalization. Current antibiotic dosing regimens often involve fixed doses based on empirical knowledge, surrogate measures (plasma samples), non-clinical evidence (experimental models), and inferior methodology (tissue specimens). Therefore, personalized antibiotic dosing may be the future of antibiotic prophylaxis to prevent postoperative infections, especially implant infections. The aim was to continuously evaluate intra- and postoperative cefuroxime target spine tissue concentrations in long-lasting spine surgery after personalized dosing by repeated weight-dosed intravenous administrations.Method: Twenty patients (15 female, 5 male) scheduled for long-lasting spine deformity surgery with hypotensive anaesthesia were included; median age (range): 17.5 years (12-74), mean BMI (range): 22.2 (16.2-37.7), and mean surgery time (range): 4h 49min (3h 57min-6h 9min). Weight-dosed cefuroxime (20 mg/kg) was administered intravenously to all patients on average 25 min before incision and repeated after 4 hours. Microdialysis catheters were placed for sampling of cefuroxime concentrations in vertebral bone (only intraoperative sampling), paravertebral muscle, and subcutaneous tissue as soon as possible after surgery start. Upon wound closure, two additional catheters were placed in the profound and superficial part of the wound. Microdialysis and plasma samples were obtained continuously intra- and postoperative for up to 12 hours. The primary endpoint was (based on cefuroxime time-dependent efficacy) the time with cefuroxime concentrations above the clinical breakpoint minimal inhibitory concentration for Staphylococcus aureus of 4 µg/mL in percentage (%fT>MIC4) ofpatients’ individual surgery time,first dosing interval (0-4 hours),second dosing interval (4-12 hours).Results: Mean cefuroxime %fT>MIC4 (range) of:patients’ individual surgery time was 100% (100-100%) in all investigated tissues.the first dosing interval was 93% (93-93%) in vertebral bone, paravertebral muscle, subcutaneous tissue, and 99% (99-100%) in plasma.the second dosing interval was 87% (52-100%) in paravertebral muscle, 89% (52-100%) in subcutaneous tissue, 91% (71-100%) in the profound wound, 94% (72-100%) in the superficial wound, and 71% (42-100%) in plasma.Conclusions: Personalized cefuroxime dosing by repeated weight-dosed (20 mg/kg) intravenous administrations provided homogenous and therapeutic spine tissue exposure across all investigated tissues and plasma in long-lasting spine surgery with hypotensive anaesthesia (up to 11 hours). Thus, personalized cefuroxime dosing may decrease the risk of postoperative spine infection, especially in cases with implant insertion.
- 22 November 2024
- Published by British Editorial Society of Bone & Joint Surgery in Orthopaedic Proceedings
- Vol. 106-B (SUPP_19) , 50
FIRST-TIME EVALUATION OF INTRA- AND POSTOPERATIVE CEFUROXIME TARGET SPINE TISSUE CONCENTRATIONS IN LONG-LASTING SPINE SURGERY FOLLOWING REPEATED WEIGHT-DOSED INTRAVENOUS ADMINISTRATIONS
Aim: Antibiotic prophylaxis is central in preventing postoperative spine infections, yet knowledge of clinical spine tissue antibiotic concentrations remains limited. Pooled postoperative spine infection rates are constant (approximately 3%), resulting in severe patient morbidity, mortality, and prolonged hospitalization. Current antibiotic dosing regimens often involve fixed doses based on empirical knowledge, surrogate measures (plasma samples), non-clinical evidence (experimental models), and inferior methodology (tissue specimens). Therefore, personalized antibiotic dosing may be the future of antibiotic prophylaxis to prevent postoperative infections, especially implant infections. The aim was to continuously evaluate intra- and postoperative cefuroxime target spine tissue concentrations in long-lasting spine surgery after personalized dosing by repeated weight-dosed intravenous administrations.Method: Twenty patients (15 female, 5 male) scheduled for long-lasting spine deformity surgery with hypotensive anaesthesia were included; median age (range): 17.5 years (12-74), mean BMI (range): 22.2 (16.2-37.7), and mean surgery time (range): 4h 49min (3h 57min-6h 9min). Weight-dosed cefuroxime (20 mg/kg) was administered intravenously to all patients on average 25 min before incision and repeated after 4 hours. Microdialysis catheters were placed for sampling of cefuroxime concentrations in vertebral bone (only intraoperative sampling), paravertebral muscle, and subcutaneous tissue as soon as possible after surgery start. Upon wound closure, two additional catheters were placed in the profound and superficial part of the wound. Microdialysis and plasma samples were obtained continuously intra- and postoperative for up to 12 hours. The primary endpoint was (based on cefuroxime time-dependent efficacy) the time with cefuroxime concentrations above the clinical breakpoint minimal inhibitory concentration for Staphylococcus aureus of 4 µg/mL in percentage (%fT>MIC4) ofpatients’ individual surgery time,first dosing interval (0-4 hours),second dosing interval (4-12 hours).Results: Mean cefuroxime %fT>MIC4 (range) of:patients’ individual surgery time was 100% (100-100%) in all investigated tissues.the first dosing interval was 93% (93-93%) in vertebral bone, paravertebral muscle, subcutaneous tissue, and 99% (99-100%) in plasma.the second dosing interval was 87% (52-100%) in paravertebral muscle, 89% (52-100%) in subcutaneous tissue, 91% (71-100%) in the profound wound, 94% (72-100%) in the superficial wound, and 71% (42-100%) in plasma.Conclusions: Personalized cefuroxime dosing by repeated weight-dosed (20 mg/kg) intravenous administrations provided homogenous and therapeutic spine tissue exposure across all investigated tissues and plasma in long-lasting spine surgery with hypotensive anaesthesia (up to 11 hours). Thus, personalized cefuroxime dosing may decrease the risk of postoperative spine infection, especially in cases with implant insertion.
- Open Access
- 22 February 2023
- Published by Wiley in British Journal of Pharmacology
- Vol. 180 (14) , 1832-1842
Evaluation of cefuroxime concentration in the intrathecal and extrathecal compartments of the lumbar spine—an experimental study in pigs
Background and PurposeOptimal antibiotic prophylaxis is crucial to prevent postoperative infection in spinal surgery. Sufficient time above the minimal inhibitory concentration (fT > MIC) for relevant bacteria in target tissues is required for cefuroxime. We assessed cefuroxime concentrations and fT > MIC of 4 mu g center dot ml(-1) for Staphylococcus aureus in the intrathecal (spinal cord and cerebrospinal fluid, CSF) and extrathecal (epidural space) compartments of the lumbar spine. Experimental ApproachEight female pigs were anaesthetized and laminectomized at L3-L4. Microdialysis catheters were placed for sampling in the spinal cord, CSF, and epidural space. A single dose of 1500 mg cefuroxime was administered intravenously over 10 min. Microdialysates and plasma were obtained continuously during 8 h. Cefuroxime concentrations were determined by ultra-high-performance liquid chromatography. Key ResultsMean fT > MIC (4 mu g center dot ml(-1)) was 58 min in the spinal cord, 0 min in the CSF, 115 min in the epidural space, and 123 min in plasma. Tissue penetration was 32% in the spinal cord, 7% in the CSF, and 63% in the epidural space. Conclusion and ImplicationsfT > MIC (4 mu g center dot ml(-1)) and tissue penetration for cefuroxime were lower in the intrathecal compartments (spinal cord and CSF) than in the extrathecal compartment (epidural space) and plasma, suggesting a significant effect of the blood-brain barrier. In terms of fT > MIC, a single dose of 1500 mg cefuroxime seems inadequate to prevent intrathecal infections related to spinal surgery for bacteria presenting with a MIC target of 4 mu g center dot ml(-1) or above.
- 22 February 2023
- Published by Wiley in British Journal of Pharmacology
- Vol. 180 (14) , 1832-1842
Open AccessEvaluation of cefuroxime concentration in the intrathecal and extrathecal compartments of the lumbar spine—an experimental study in pigs
Background and PurposeOptimal antibiotic prophylaxis is crucial to prevent postoperative infection in spinal surgery. Sufficient time above the minimal inhibitory concentration (fT > MIC) for relevant bacteria in target tissues is required for cefuroxime. We assessed cefuroxime concentrations and fT > MIC of 4 mu g center dot ml(-1) for Staphylococcus aureus in the intrathecal (spinal cord and cerebrospinal fluid, CSF) and extrathecal (epidural space) compartments of the lumbar spine. Experimental ApproachEight female pigs were anaesthetized and laminectomized at L3-L4. Microdialysis catheters were placed for sampling in the spinal cord, CSF, and epidural space. A single dose of 1500 mg cefuroxime was administered intravenously over 10 min. Microdialysates and plasma were obtained continuously during 8 h. Cefuroxime concentrations were determined by ultra-high-performance liquid chromatography. Key ResultsMean fT > MIC (4 mu g center dot ml(-1)) was 58 min in the spinal cord, 0 min in the CSF, 115 min in the epidural space, and 123 min in plasma. Tissue penetration was 32% in the spinal cord, 7% in the CSF, and 63% in the epidural space. Conclusion and ImplicationsfT > MIC (4 mu g center dot ml(-1)) and tissue penetration for cefuroxime were lower in the intrathecal compartments (spinal cord and CSF) than in the extrathecal compartment (epidural space) and plasma, suggesting a significant effect of the blood-brain barrier. In terms of fT > MIC, a single dose of 1500 mg cefuroxime seems inadequate to prevent intrathecal infections related to spinal surgery for bacteria presenting with a MIC target of 4 mu g center dot ml(-1) or above.
- Open Access
- 28 November 2022
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 93, 874-879
Subtherapeutic levels of cefuroxime inside a cannulated pedicle screw used in spine surgery: results from a porcine microdialysis study
Background and purpose: Minimally invasive spine surgery has continuously evolved for specific surgical procedures and patient populations to lower morbidity and the risk of postoperative bacterial infection. Perioperative antibiotic prophylaxis is an important preventive measure and local tissue concentrations can be quantified with microdialysis. Insertion of spinal implants induces tissue trauma and inflammation, which may affect antibiotic proximate implant concentrations. We compared perioperative cefuroxime concentrations inside a cannulated pedicle screw used in minimally invasive spine surgery with the opposite non-instrumented vertebral pedicle.Materials and methods: Microdialysis catheters were placed inside a cannulated pedicle screw and in the opposite non-instrumented vertebral pedicle of the same vertebra (L1) in 8 female pigs through a posterior lumbar surgical approach. Following a single-dose intravenous cefuroxime administration (1.5 g), dialysates and plasma were dynamically sampled over 8 hours. The primary endpoint was time above the cefuroxime clinical breakpoint minimal inhibitory concentration for Staphylococcus aureus of 4 μg/mL (T>MIC4).Results: Median T>MIC4 was 0 h (range 0–0) inside the cannulated pedicle screw, 1.6 h (range 1.1–2.4) in non-instrumented vertebral pedicle, and 1.9 h (range 1.9–2.9) in plasma.Conclusion: A single-dose intravenous cefuroxime administration provided low and subtherapeutic concentrations for prevention of infection inside a cannulated pedicle screw in the lumbar spine. Therapeutic concentrations were achieved in the opposite non-instrumented vertebral pedicle up to 1.5–2 h. Therefore, additional prophylactic strategies may be considered in cannulated instrumented spine surgery, especially in high-risk patients. Alternative dosing regimens seem relevant in lumbar spine surgery lasting longer than 1.5 h.
- 28 November 2022
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 93, 874-879
Open AccessSubtherapeutic levels of cefuroxime inside a cannulated pedicle screw used in spine surgery: results from a porcine microdialysis study
Background and purpose: Minimally invasive spine surgery has continuously evolved for specific surgical procedures and patient populations to lower morbidity and the risk of postoperative bacterial infection. Perioperative antibiotic prophylaxis is an important preventive measure and local tissue concentrations can be quantified with microdialysis. Insertion of spinal implants induces tissue trauma and inflammation, which may affect antibiotic proximate implant concentrations. We compared perioperative cefuroxime concentrations inside a cannulated pedicle screw used in minimally invasive spine surgery with the opposite non-instrumented vertebral pedicle.Materials and methods: Microdialysis catheters were placed inside a cannulated pedicle screw and in the opposite non-instrumented vertebral pedicle of the same vertebra (L1) in 8 female pigs through a posterior lumbar surgical approach. Following a single-dose intravenous cefuroxime administration (1.5 g), dialysates and plasma were dynamically sampled over 8 hours. The primary endpoint was time above the cefuroxime clinical breakpoint minimal inhibitory concentration for Staphylococcus aureus of 4 μg/mL (T>MIC4).Results: Median T>MIC4 was 0 h (range 0–0) inside the cannulated pedicle screw, 1.6 h (range 1.1–2.4) in non-instrumented vertebral pedicle, and 1.9 h (range 1.9–2.9) in plasma.Conclusion: A single-dose intravenous cefuroxime administration provided low and subtherapeutic concentrations for prevention of infection inside a cannulated pedicle screw in the lumbar spine. Therapeutic concentrations were achieved in the opposite non-instrumented vertebral pedicle up to 1.5–2 h. Therefore, additional prophylactic strategies may be considered in cannulated instrumented spine surgery, especially in high-risk patients. Alternative dosing regimens seem relevant in lumbar spine surgery lasting longer than 1.5 h.
- Open Access
- 6 June 2022
- Published by Elsevier in The Spine Journal
- Vol. 22 (9) , 1434-1441
Cefuroxime concentrations in the anterior and posterior column of the lumbar spine – an experimental porcine study
- 6 June 2022
- Published by Elsevier in The Spine Journal
- Vol. 22 (9) , 1434-1441
Open AccessCefuroxime concentrations in the anterior and posterior column of the lumbar spine – an experimental porcine study